Osteoarthritis (OA) is the most common cause of chronic pain in dogs and can significantly impact their mobility and quality of life. The disease can begin in very young dogs and it progresses over time. Disease-modifying osteoarthritis drugs (DMOADs) are one class of drugs that can actually slow progression of the disease by reducing loss of cartilage and improving joint health. Adequan (polysulfated glycosaminoglycan) is a commercially available DMOAD that is commonly used early in the course of the disease to proactively slow the loss of cartilage in the dog's joints. There are recommended protocols to achieve the best result. In this segment Dr. James Gaynor - a veterinary pain management expert - addresses a commonly asked question about the dosing of Adequan and shares his approach to the use of this drug in dogs. Learn more about arthritis pain management: https://bit.ly/VetVine_Gaynor

You might also like

"Today" Web "18" ?

03/30/2024

Describe here 

Read More

Cat Care Event

02/15/2024

Cat care eventCat care eventCat care eventCat care eventCat care eventCat care eventCat care eventCa...

Read More

Tips for Veterinary Professionals: Communicating About Pain with Pet Owners

09/04/2023

Many pet owners fail to recognize the subtle signs and symptoms of pain in dogs and cats. If a pet i...

Read More

Pain in Animals - The bad news and why we must care

08/30/2023

Dr. Jennifer Johnson - a veterinarian and pain management expert - explains just how common pain ass...

Read More

Autoimmune Disease Should We Vaccinate Affected Pets

08/16/2023

Dr. Rebecca Windsor - a board certified veterinary neurologist - recently talked to us about a varie...

Read More

Immune-mediated Neuroinflammatory Diseases

08/15/2023

Presented by Dr. Rebecca Windsor Access an evaluation / Earn CE credit by viewing this in its e...

Read More